Hyperbaric Oxygen Dementia Research: What Exists Today

What does research say about hyperbaric oxygen and dementia?

The dementia-related hyperbaric literature consists mainly of small studies, case series, and reviews examining cognition and cerebral blood flow in older adults. Reviews consistently conclude that current evidence is insufficient to support hyperbaric oxygen as a dementia intervention.

Dementia care guidelines from major medical organizations do not include hyperbaric oxygen, and researchers describe the area as needing larger, better-controlled trials.

Research in this area is ongoing and results to date are preliminary. Published studies vary in size, pressure levels, and session protocols, and major health authorities have not approved hyperbaric oxygen therapy for this condition. This article summarizes the research topic for educational purposes only.

Why do families and individuals explore mild HBOT for dementia?

Interest in mild hyperbaric sessions among people affected by dementia generally centers on the same general wellness themes reported by other users of mHBOT — relaxation, routine, and structured recovery time in a controlled environment.

OxyEdge chambers are wellness products and are not intended to diagnose, treat, cure, or prevent any disease. Hyperbaric oxygen therapy is not FDA-cleared for this use. Anyone considering hyperbaric sessions in connection with a health condition should consult a licensed physician first.

What is mild hyperbaric oxygen therapy (mHBOT)?

Mild hyperbaric oxygen therapy involves sitting or reclining inside a sealed chamber pressurized above normal atmospheric pressure, generally between 1.3 and 2.0 ATA, while breathing supplemental oxygen from a concentrator. Sessions typically last 60 to 90 minutes.

Hard-shell chambers hold pressure precisely because their rigid walls do not flex. OxyEdge manufactures only hard-shell chambers and does not sell soft-shell inflatable units, which are more prone to leaks and pressure loss.

Clinic-grade equipment for home use: the OxyEdge approach

OxyEdge manufactures the same hard-shell mild hyperbaric chambers used by wellness clinics, now available for in-home use through the OxyEdge OS™ operating system. OxyEdge OS automates pressurization, session protocols, and real-time monitoring so a home user operates clinic-grade equipment with guided, repeatable sessions.

Every OxyEdge chamber is a rigid hard-shell vessel operating in the mild hyperbaric range up to 2.0 ATA, built in the USA with ISO 13485 / ISO 9001 compliant manufacturing, and backed by a Five-Year Limited Warranty with lifetime support.

Frequently Asked Questions

Is hyperbaric oxygen part of standard dementia care?

No. Dementia care guidelines do not include hyperbaric oxygen, and the research to date is limited and inconclusive.

How is an OxyEdge home chamber operated?

OxyEdge OS™ automates pressurization, session protocols, and monitoring, so an operator or caregiver starts a guided session rather than managing pressure manually.

Is hyperbaric oxygen therapy approved to treat dementia?

No. Hyperbaric oxygen therapy is not FDA-cleared for dementia. Published research is exploratory, and OxyEdge chambers are wellness products that make no medical treatment claims. Consult a licensed physician about any health condition.

Is an OxyEdge home chamber the same as a clinic chamber?

OxyEdge builds the same hard-shell mild hyperbaric chambers used by wellness clinics, with the OxyEdge OS™ operating system adapting clinic-grade equipment for guided in-home use.